ZA951343B - Enantiomerically pure (+)-liarozole - Google Patents

Enantiomerically pure (+)-liarozole

Info

Publication number
ZA951343B
ZA951343B ZA951343A ZA951343A ZA951343B ZA 951343 B ZA951343 B ZA 951343B ZA 951343 A ZA951343 A ZA 951343A ZA 951343 A ZA951343 A ZA 951343A ZA 951343 B ZA951343 B ZA 951343B
Authority
ZA
South Africa
Prior art keywords
liarozole
enantiomerically pure
enantiomerically
pure
Prior art date
Application number
ZA951343A
Inventor
Marc Gaston Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA951343B publication Critical patent/ZA951343B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA951343A 1994-02-18 1995-02-17 Enantiomerically pure (+)-liarozole ZA951343B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200420 1994-02-18

Publications (1)

Publication Number Publication Date
ZA951343B true ZA951343B (en) 1996-08-19

Family

ID=8216652

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951343A ZA951343B (en) 1994-02-18 1995-02-17 Enantiomerically pure (+)-liarozole

Country Status (12)

Country Link
EP (1) EP0745077A1 (en)
JP (1) JPH09508914A (en)
CN (1) CN1141042A (en)
AU (1) AU689206B2 (en)
CA (1) CA2182583A1 (en)
IL (1) IL112688A0 (en)
MX (1) MX9603316A (en)
NZ (1) NZ279227A (en)
SG (1) SG52325A1 (en)
TW (1) TW401415B (en)
WO (1) WO1995022540A1 (en)
ZA (1) ZA951343B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800391A1 (en) * 1994-12-28 1997-10-15 Janssen Pharmaceutica N.V. Benzimidazoles as inhibitors of calcitriol metabolism
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives
US9138393B2 (en) * 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) * 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders

Also Published As

Publication number Publication date
IL112688A0 (en) 1995-05-26
MX9603316A (en) 1997-02-28
TW401415B (en) 2000-08-11
AU689206B2 (en) 1998-03-26
WO1995022540A1 (en) 1995-08-24
CA2182583A1 (en) 1995-08-24
EP0745077A1 (en) 1996-12-04
CN1141042A (en) 1997-01-22
JPH09508914A (en) 1997-09-09
NZ279227A (en) 1997-11-24
SG52325A1 (en) 1998-09-28
AU1578795A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
DE69512030D1 (en) Cerebral-dilator
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69429543D1 (en) Koagulationszange
DE69504528D1 (en) Quenchkühler
DE59503634D1 (en) Friercontainer
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
SG52325A1 (en) Enantiomerically pure(+)-liarozole
SG73418A1 (en) Novel dihydrodibenzoquinolinediones
AU122938S (en) Breadbox
DE69508761D1 (en) Haloalkylierungsverfahren
ZA951342B (en) Enantiomerically pure (-)-liarozole
DE69506730D1 (en) Differentialer antriebsmechanismus
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE69502834D1 (en) Vinylperfluorcyclopropanpolymere
DE69504062D1 (en) Spandexlieferspule
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen
DE59503452D1 (en) Piezoresistiver widerstand
HU9402476D0 (en) (piperidino-alkyl)-aryl-ethers
CA74714S (en) Can
CA73798S (en) Air-purifier
CA73835S (en) Air-purifier
SG33449A1 (en) Novel pyrrolocarbazoles